13856 research outputs found
Sort by
移動可能な巻線を有する磁気共鳴画像装置,および,当該磁気共鳴画像装置を用いた治療システム
No full text[[abstract]]A magnetic resonance imaging system to be used over a target area of a subject includes first and second RF coils for receiving an RF signal from the subject. The first RF coil is fixed to a position device and movable over the target area of subject. The second RF coil is larger than the first RF coil and has a larger field of view than the first RF coil. The system further includes an image processing device programmed to process RF signals coupled from the first RF coil and the second RF coil to form an MRI image
多重超音波フェーズドアレイ駆動システム
No full text[[abstract]]An apparatus for sonicating a patient includes an ultrasound array having a plurality of transducers; a driving module for driving said transducers; and a control kernel for causing said driving module to drive said transducers concurrently at two different frequencies
[[alternative]]Method of removing motion-induced ghost artifacts in mri
No full text[[abstract]]本發明提供一個修正磁振造影中移動假影的方法，其中可於磁振造影掃描取得影像後，透過自動化影像分割與假影消除演算法，對物體移動所產生的相位誤差進行補償，以達到最小背景假影訊號強度進而得到修正移動假影後的影像
作爲酪胺酸激酶抑制劑的稠合雙環及多環嘧啶化合物
No full text[[abstract]]本發明揭露一種本文定義的式(I)稠合雙環或多環化合物。本發明也揭露一種抑制EGFR激酶活性的方法，以及一種以這些化合物治療癌症的方法
[[alternative]]Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
No full text[[abstract]]Fused bicyclic or tricyclic compounds of formula (I): wherein A, B, C, X, Y, m, and n are defined herein. Also disclosed are a method for inhibiting EGFR kinase activity and a method for treating cancer with these compounds
Fullerene pharmaceutical compositions for preventing or treating disorders
No full text[[abstract]]The present invention relates to a method for treating a disease, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a fullerene. The diseases treated comprise bacterial and viral diseases such as those cause by Gram positive and Gram negative bacteria, Dengue 2 virus and viral encephalitis. The fullerene is administered in vivo in an amount of about 0.001 to about 100 mg/kg of body weight of the subject
Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine
No full text[[abstract]]The present invention relates to a method for decreasing the psychotomimetic side effects and enhancing the antidepressant-like effects of ketamine by the combination of ketamine with a methylglycine derivative. The present invention also relates to a method for depression treatment comprising administrating ketamine combined with a methylglycine derivative. The present invention further provides a method for preventing or treating addictive disorders of ketamine by administrating a methylglycine derivative
Method and composition for decreasing the pschotomimetic and addictive disorder of ketamine
No full text[[abstract]]The present invention relates to a method for decreasing the psychotomimetic side effects and enhancing the antidepressant-like effects of ketamine by the combination of ketamine with a methylglycine derivative. The present invention also relates to a method for depression treatment comprising administrating ketamine combined with a methylglycine derivative. The present invention further provides a method for preventing or treating addictive disorders of ketamine by administrating a methylglycine derivative
항-A베타 항체 및 이의 용도
No full text[[abstract]]서열번호 1, 서열번호 7, 또는 서열번호 14의 서열을 갖는 경쇄 CDR1 (L-CDR1); 서열번호 2 또는 서열번호 15의 서열을 갖는 경쇄 CDR2 (L-CDR2); 서열번호 3, 서열번호 8, 서열번호 21, 또는 서열번호 24의 서열을 갖는 경쇄 CDR3 (L-CDR3); 서열번호 4, 서열번호 9, 서열번호 11, 서열번호 16, 또는 서열번호 25의 서열을 갖는 중쇄 CDR1 (H-CDR1); 서열번호 5, 서열번호 12, 서열번호 17, 서열번호 19, 서열번호 22, 또는 서열번호 26의 서열을 갖는 중쇄 CDR2 (H-CDR2); 및 서열번호 6, 서열번호 10, 서열번호 13, 서열번호 18, 서열번호 20, 서열번호 23, 또는 서열번호 27의 서열을 갖는 중쇄 CDR3 (H-CDR3)를 포함하는 단리된 항체로서, 여기서 항체는 Aβ1-42 또는 이의 N-말단 변형 형태에 특이적으로 결합한다
抗-乙型澱粉樣蛋白抗體及其用途
No full text[[abstract]]一種分離的抗體，其結構包含：輕鏈CDR1，輕鏈CDR2，重鏈CDR1，重鏈CDR2，以及重鏈CDR3，所述抗體對Aβ₁₋₄₂或一N端修飾型Aβ₁₋₄₂都具有特異性結合能力。該抗體可用於治療AD和早期檢測腦Aβ含量。N端修飾的焦麩氨酸Aβ(pE‑Aβ3‑42)非常易於聚集，並且對Aβ斑塊